Insights

Perspective, tips, and resources for moving health forward

All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health
Lash Group

Navigating the payer landscape for digital therapeutics

Lash Group
June 2021

Manufacturers

Patient support for digital therapeutics: Do's and don'ts for designing your program

Lash Group
June 2021

Manufacturers

Work worth doing: Innovative field solutions

Melissa Mulchahey
Xcenda
June 2021

Manufacturers

Innomar Strategies: 20 years of innovative market access solutions

Innomar Strategies
June 2021

Manufacturers

Work worth doing: FormularyDecisions

Laurie Fazio
Xcenda
May 2021

Manufacturers

The essential guide to drug commercialization

AmerisourceBergen
May 2021

Manufacturers

Podcast: ThinkLive Commercialization 2021

tommy bramley lash group
Tommy Bramley, PhD; Matt Sarnes, PharmD; Brian Ansay
Lash Group
May 2021

Manufacturers

On-demand webinar: Accelerating access to therapy (a view from the front lines)

AmerisourceBergen
April 2021
Accelerating access to therapy

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

AmerisourceBergen
April 2021

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

AmerisourceBergen
April 2021
Strategic partnerships for unlocking product potential ebook

Manufacturers

The Value of Real-World Evidence in Canadian Drug Commercialization: Part 2

Innomar Strategies
April 2021

Manufacturers

How to make the most of integrated commercialization solutions

Glen Martin
AmerisourceBergen
March 2021
AmerisourceBergen manufacturer commercialization strategies

Manufacturers

Strategies for addressing copay accumulators: What manufacturers need to know

Corey Ford
Corey Ford, MHA; Dale Hanna
Xcenda
March 2021

Manufacturers

Webinar: uptake or heartbreak with biosimilars? Progress and perspectives

AmerisourceBergen
February 2021
Market access professionals

Manufacturers

Pre-launch checklist: What to look for in a commercialization partner

AmerisourceBergen
February 2021

Manufacturers

Checklist: Four things to look for in a field services partner

Xcenda
February 2021
xcenda field services working on project

Manufacturers

Case study: an innovative field reimbursement program expands patient access

Xcenda
January 2021

Manufacturers

Cell and gene therapies: bringing innovation to market

AmerisourceBergen
December 2020
Lab tech with DNA

Manufacturers

Pharma in the field: Ashley's story

Xcenda
November 2020
Doctor talking to patient

Manufacturers

Pharma in the field: Tierra's story

Xcenda
November 2020

Manufacturers

Ebook: Virtual drug commercialization

AmerisourceBergen
November 2020

Manufacturers

Is a contact-free clinical trial possible?

Portrait of Mike Sweeney
Mike Sweeney; Kim McLeod, MPH
World Courier
September 2020

Patient support launch guide: novel therapies 

Lash Group
September 2020
Man working on a laptop computer

Manufacturers

Is your PIE incomplete?

Xcenda
September 2020

Manufacturers

Rethink field services: Three myths keeping access barriers in front of your product

Melissa Mulchahey
Xcenda
August 2020
female_doctor_virtual_visit

Manufacturers

Solving access, reimbursement, and PAP awareness problems

Xcenda
August 2020
Male doctor speaking to patient on a tablet

Manufacturers

Pharma in the field: Sales reps vs. reimbursement and access specialists

Xcenda
July 2020

Manufacturers

The Future of Payer Engagement: How Pharma Can Break Through

Matt Sarnes, PharmD; Allen Lising
June 2020

Manufacturers

The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving

AmerisourceBergen icon
Bre Penzner; Nancy Young
Xcenda
May 2020

Manufacturers

Distant But Engaged: Transitioning to Virtual Training

Bryan Horveath
Bryan Horveath, MS
May 2020

Manufacturers

Mind the (Evidence) Gap

Kim McLeod
Kim McLeod, MPH
Xcenda
February 2020

Manufacturers

InnomarLive 2019: Commercializing in Canada

Innomar Strategies
December 2019

Manufacturers

Biosimilars: Market Insights and Growth Factors

Sean McGowan; Rick Lozano
AmerisourceBergen
September 2019

The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.

Manufacturers

Biosimilars: Launch Insights From the Field

Melissa Mulchahey
Xcenda
September 2019

How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.

Manufacturers

How Digital Innovation Drives Improved Market Access Strategies

Xcenda
July 2019

In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?

Health Systems

Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies

AmerisourceBergen
April 2019

Download this new white paper from IHOC - Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies - to learn the key insights about the role HSSPs play in improving the patient experience and why patient and provider satisfaction are important data points for both payers and manufacturers to consider when deciding to include HSSPs in their networks.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Ana Stojanovska
June 2018

An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Ana Stojanovska
June 2018

An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.

Infographic: The Road to Commercialization in Canada

AmerisourceBergen
May 2018

Manufacturers

What Do Payers Think About Digital Health Technologies

AmerisourceBergen
September 2017

How are payers thinking about apps, wearables and other digital health technologies?

Manufacturers

The Route to Market Access in Canada

Innomar Strategies
September 2017

Understanding the unique considerations for reimbursement in the Canadian pharmaceutical market.